Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
EF 2026-2027
Canada
The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commerc...
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
EF 2022-2023
Canada
The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
EF 2019-2020
Canada
Support a diverse portfolio of health-related research and knowledge translation projects at any stage, from discovery to application, including commercialization; Promote relevant collaborations acro...
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada
Identification of miRNAs and their Specific Gene Targets that are Critical for Prostate Cancer Metastases
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2017-2018
Canada
Identification of HP1a as a key regulator and a novel therapeutic target for neuroendocrine prostate cancer
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
EF 2020-2021
Canada
The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada
Next generation patient-derived, genetically-defined prostate cancer xenograft models for anti- cancer drug development
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2016-2017
Canada
Application of antibody internalization domain to improve the efficacy and safety of Antibody Drug Conjugates
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2015-2016
Canada
Next generation patient-derived, genetically-defined kidney and bladder cancer xenograft models for anti-cancer drug development
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2022-2023
Canada
• The CIHR Institute of Cancer (CIHR-ICR) will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Cancer Research (ICR) supports research that redu...
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2025-2026
Canada
The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, ef...
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2024-2025
Canada
The specific objectives of this funding opportunity are:
• to support planning activities, partnership development and to increase understanding of the health research landscape that will contribu...